Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chrysovalantis Voutouri

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 1, 2019
Experimental and computational analyses reveal dynamics of tumor vessel cooption and optimal treatment strategiesChrysovalantis Voutouri, Nathaniel D Kirkpatrick, Euiheon Chung, et al.
Materials Science & Engineering. C, Materials for Biological Applications|September 30, 2020
Engineered magnetoactive collagen hydrogels with tunable and predictable mechanical responseSavvas Karagiorgis, Alkiviadis Tsamis, Chrysovalantis Voutouri, et al.
Molecular Cancer Therapeutics|May 2, 2026
Synthetic inducible bacteria normalize the microenvironment of refractory tumors, potentiating checkpoint inhibitor responsesMyrofora Panagi, Fotios Mpekris, Marcos Burger Ramos, et al.
Molecular Cancer Therapeutics|May 18, 2026
Synthetic Inducible Bacteria Normalize the Microenvironment of Refractory Tumors, Potentiating Checkpoint Inhibitor ResponsesMyrofora Panagi, Fotios Mpekris, Marcos Burger Ramos, et al.
Plos One|May 31, 2024
Dynamic heterogeneity in COVID-19: Insights from a mathematical modelChrysovalantis Voutouri, C Corey Hardin, Vivek Naranbhai, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 14, 2022
Translational nanomedicine potentiates immunotherapy in sarcoma by normalizing the microenvironmentFotios Mpekris, Myrofora Panagi, Christina Michael, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2023
Mechanistic model for booster doses effectiveness in healthy, cancer, and immunosuppressed patients infected with SARS-CoV-2Chrysovalantis Voutouri, C Corey Hardin, Vivek Naranbhai, et al.
Cell Reports. Medicine|March 20, 2024
In silico clinical studies for optimal COVID-19 vaccination schedules in patients with cancerChrysovalantis Voutouri, C Corey Hardin, Vivek Naranbhai, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 6, 2021
In silico dynamics of COVID-19 phenotypes for optimizing clinical managementChrysovalantis Voutouri, Mohammad Reza Nikmaneshi, C Corey Hardin, et al.
Research Square|September 10, 2020
In silico dynamics of COVID-19 phenotypes for optimizing clinical managementChrysovalantis Voutouri, Mohammad Reza Nikmaneshi, C Corey Hardin, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|February 1, 2019
Experimental and computational analyses reveal dynamics of tumor vessel cooption and optimal treatment strategiesChrysovalantis Voutouri, Nathaniel D Kirkpatrick, Euiheon Chung, et al.
Materials Science & Engineering. C, Materials for Biological Applications|September 30, 2020
Engineered magnetoactive collagen hydrogels with tunable and predictable mechanical responseSavvas Karagiorgis, Alkiviadis Tsamis, Chrysovalantis Voutouri, et al.
Molecular Cancer Therapeutics|May 2, 2026
Synthetic inducible bacteria normalize the microenvironment of refractory tumors, potentiating checkpoint inhibitor responsesMyrofora Panagi, Fotios Mpekris, Marcos Burger Ramos, et al.
Molecular Cancer Therapeutics|May 18, 2026
Synthetic Inducible Bacteria Normalize the Microenvironment of Refractory Tumors, Potentiating Checkpoint Inhibitor ResponsesMyrofora Panagi, Fotios Mpekris, Marcos Burger Ramos, et al.
Plos One|May 31, 2024
Dynamic heterogeneity in COVID-19: Insights from a mathematical modelChrysovalantis Voutouri, C Corey Hardin, Vivek Naranbhai, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 14, 2022
Translational nanomedicine potentiates immunotherapy in sarcoma by normalizing the microenvironmentFotios Mpekris, Myrofora Panagi, Christina Michael, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2023
Mechanistic model for booster doses effectiveness in healthy, cancer, and immunosuppressed patients infected with SARS-CoV-2Chrysovalantis Voutouri, C Corey Hardin, Vivek Naranbhai, et al.
Cell Reports. Medicine|March 20, 2024
In silico clinical studies for optimal COVID-19 vaccination schedules in patients with cancerChrysovalantis Voutouri, C Corey Hardin, Vivek Naranbhai, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 6, 2021
In silico dynamics of COVID-19 phenotypes for optimizing clinical managementChrysovalantis Voutouri, Mohammad Reza Nikmaneshi, C Corey Hardin, et al.
Research Square|September 10, 2020
In silico dynamics of COVID-19 phenotypes for optimizing clinical managementChrysovalantis Voutouri, Mohammad Reza Nikmaneshi, C Corey Hardin, et al.
Pageof 5